Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens

Fertility and Sterility

Volumn 85, Issue 5, 2006, Pages 1441-1447

  Sepilian, Vicken P ^a   Crochet, John R ^a   Nagamani, Manubai ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

free leptin index; Leptin; polycystic ovarian syndrome (PCOS); soluble leptin receptor (sOB R)

Indexed keywords

ANDROGEN; GLUCOSE; INSULIN; LEPTIN RECEPTOR; ROSIGLITAZONE;

ADULT; ARTICLE; BODY MASS; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HORMONE RESISTANCE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEPTOR SOLUBILIZATION;

ACANTHOSIS NIGRICANS; ADIPOSITY; ADULT; ANDROGENS; BODY MASS INDEX; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; INSULIN RESISTANCE; LEPTIN; OBESITY; POLYCYSTIC OVARY SYNDROME; RECEPTORS, CELL SURFACE; RISK ASSESSMENT; RISK FACTORS; TEXAS;

EID: 33646120575     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.10.038     Document Type: Article

References (53)

1. Zhang Y.Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homolog. Nature 372 (1994) 425-432
2. Chehab F., Lim M., and Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12 (1996) 318
3. Jockenhovel F., Blum W., Vogel E., Englaro P., Muller-Wieland D., and Reinwein D. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab 82 (1997) 2510-2513
4. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83 (1995) 1263-1271
5. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., et al. The evidence that the diabetes gene encodes the leptin receptor. identification of a mutation in the leptin receptor gene in db/db mice. Cell 84 (1996) 491-495
6. Lee G.-H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379 (1996) 632-635
7. Liu C., Liu X., Barry G., Ling N., Maki R., and De Souza E. Expression and characterisation of a putative high affinity human soluble leptin receptor. Endocrinology 138 (1997) 3548-3554
8. Diamond F.B., Eichler D.C., Duckett G., Jorgensen E.V., Shulman D., and Root A.W. Demonstration of a leptin binding factor in human serum. Biochem Biophys Res Commun 233 (1997) 818-822
9. Sinha M.K., Opentanova I., Ohannesian JPKolaczynski J.W., Heiman M.L., Hale J., et al. Evidence of free and bound leptin in human circulation. studies in lean and obese subjects and during short-term fasting. J Clin Invest 98 (1996) 1277-1282
10. Maamra M., Bidlingmaier M., Postel-Vinay M.C., Wu Z., Strasburger C.J., and Ross R.J. Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology 142 (2001) 4389-4393
11. Ge H., Huang L., Pourbahrami T., and Li C. Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J Biol Chem 277 (2002) 45898-45903
12. Huang L., Wang Z., and Li C. Modulation of circulating leptin levels by its soluble receptor. J Biol Chem 276 (2001) 6343-6349
13. Yang G., Ge H., Boucher A., Yu X., and Li C. Modulation of direct leptin signaling by soluble leptin receptor. Mol Endocrinol 18 (2004) 1354-1362
14. Carmina E., and Lobo R.A. Polycystic ovary syndrome (PCOS). arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84 (1999) 1897-1899
15. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern United States. a prospective study. J Clin Endocrinol Metab 83 (1998) 3078-3082
16. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome. a prospective controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
17. Dunaif A. Insulin resistance and polycystic ovary syndrome. mechanism and implications for pathogenesis. Endocrinol Rev 18 (1997) 774-800
18. Brzechffa P.R., Jakimiuk A.J., Agarawi S.K., Weitsman S.R., Buyalos R.P., and Magoffin D.A. Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 81 (1996) 4166-4168
19. El Orabi H., Ghalia A.A., Khalifa A., Mahfouz H., Shalkani A., and Shoeib N. Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome. Clin Biochem 32 (1999) 71-75
20. Vicennati V., Gambineri A., Calzoni F., Casimirri F., Macor C., Vettor R., et al. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels. Metabolism 48 (1998) 988-992
21. Remsberg K., Talbott E., Zborowski J., Evans R., and McHugh-Pemu K. Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome. Fertil Steril 78 (2002) 479-486
22. Rouru J., Anttila L., Koskinen P., Penttila T.A., Irjala K., Huupponen R., et al. Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82 (1997) 1697-1700
23. Spritzer P.M., Poy M., Mylius L.S., and Capp E. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism. influence on LH and relationship with hormonal, metabolic, and anthropometric measurements. Hum Reprod 16 (2001) 1340-1346
24. Nader S., Riad-Gabriel M.G., and Saad M.F. The effect of desogesterel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women. J Clin Endocrinol Metab 82 (1997) 3074-3077
25. Stuart S.A., Gilkison C.R., Smith M.M., Bosma A.M., Keenan B.S., and Nagamani M. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr 37 (1998) 73-80
26. Barbieri R.L. Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress. J Reprod Med 39 (1994) 327-336
27. Zawadski J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome. towards a rational approach. In: Dunaif A., Givens J.R., and Haseltine F. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific, Boston 377-384
28. Havel P.J., Kasim-Karakas S., Mueller W., Johnson P.R., Gingerich R.L., and Stern J.S. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women. effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 81 (1996) 4406-4413
29. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 (1995) 543-546
30. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269 (1995) 540-543
31. Weigle D.S., Bukowski T.R., Foster D.C., Holderman S., Kramer J.M., Lasser G., et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 96 (1995) 2065-2070
32. Hardie L.J., Rayner D.V., Holmes S., and Trayhurn P. Circulating leptin levels are modulated by fasting, cold exposure, and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA. Biochem Biophys Res Commun 223 (1996) 660-665
33. Cusin I., Sainsbury A., Doyle P., Rohner-Jeanrenaud F., and Jeanrenaud B. The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 44 (1995) 1467-1470
34. Wabitsch M., Jenson P.B., Blim W.F., Christoffersen C.T., Englaro P., Heinze E., et al. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 45 (1996) 1435-1438
35. Kolaczynski J.W., Nyce M.R., Considine R.V., Boden G., Nolan J.J., Henry R., et al. Acute and chronic effect of insulin on leptin production in humans. Diabetes 45 (1996) 699-701
36. Lewandowski K., Randeva H.S., O'Callaghan C.J., Horn R., Medley G.F., Hillhouse E.W., et al. Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin. Clin Endocrinol 54 (2001) 533-539
37. Chan J.L., Bluher S., Yiannakouris N., Suchard M.A., Kratzsch J., and Mantzoros C.S. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin. observational and interventional studies in humans. Diabetes 51 (2002) 2105-2112
38. Leonhardt W., Horn R., Brabant G., Breidert M., Temelkova-Kurktschiev T., Fucker K., et al. Relation of free and specifically bound leptin to insulin secretion in patients with impaired glucose tolerance. Exp Clin Endocrinol Diabetes 107 (1999) 46-52
39. Yannakoulia M., Yiannakouris N., Bluher S., Matalas A.L., Klimis-Zacas D., and Mantzoros C.S. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88 (2003) 1730-1736
40. Lahlou N., Clement K., Carel J.C., Vaisse C., Lotton C., Le Bihan Y., et al. Soluble leptin receptor in serum of subjects with complete resistance to leptin. Diabetes 49 (2000) 347-352
41. Misra M., Miller K.K., Almazan C., Ramaswamy K., Aggarwal A., Herzog D.B., et al. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 89 (2004) 3486-3495
42. Brabant G., Horn R., von zur Mühlen A., Mayr B., Wurster U., Heidenreich F., et al. Free and protein bound leptin are distinct and independently controlled factors in energy regulation. Diabetologia 43 (2000) 438-442
43. Ogawa T., Hiroshi H., Yamamoto Y., Nishikai K., Miyashita K., Nakamura H., et al. Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphism in the Japanese population. Metabolism 53 (2004) 879-885
44. Chan J.L., Bluher S., Yiannakouris N., Suchard M.A., Kratzsch J., and Mantzoros C.S. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin. observational and interventional studies in humans. Diabetes 51 (2002) 2105-2112
45. Phillips S.A., Ciaraldi T.P., Kong A.P., Bandukwala R., Aroda V., Carter L., et al. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes 52 (2003) 667-4
46. Lewandowski K., Randeva H.S., O'Callaghan C.J., Horn R., Medley G.F., Hillhouse E.W., et al. Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin. Clin Endocrinol 54 (2001) 533-539
47. Kratzsch J., Deimel A., Galler A., Kapellen T., Klinghammer A., and Keiss W. Increased serum soluble leptin receptor levels in children and adolescents with type 1 diabetes mellitus. Eur J Endocrinol 151 (2004) 475-481
48. Tedde R., Pala A., Melis A., Sechi G., Bilotta F., and Realdi G. Hyperinsulinemia and hypertension. Do intestinal hormones play a role?. Am J Hyperten 8 (1995) 99-103
49. Mersebach H., Svendsen O.L., Holst J.J., Astrup A., and Feldt-Rasmussen U. Comparison of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals. Clin Endocrinol 58 (2003) 65-71
50. Richard R.J., Porter J., and Svec F. Serum leptin, lipids, free fatty acids, and fat pads in long-term dehydroepiandrosterone-treated Zucker rats. Proc Soc Exp Biol Med 223 (2000) 258-262
51. l'Allemand D., Schmidt S., Rousson V., Brabant G., Gasser T., and Gruters A. Associations between body mass, leptin, IGF-I, and circulating adrenal androgens in children with obesity and premature adrenarche. Eur J Endocrinol 146 (2002) 537-543
52. Lambrinoudaki I., Christodoulakos G., Panoulis C., Botsis D., Rizos D., Augoulea A., et al. Determinants of serum leptin levels in healthy postmenopausal women. J Endocrinol Invest 26 (2003) 1225-1230
53. Callies F., Fassnacht M., van Vlijmen J.C., Koehler I., Huebler D., Seibel M.J., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. effects on body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol Metab 86 (2001) 1968-1972